Assessment of compliance with antipsychotic treatment and resource utilization in a medicaid population

被引:85
作者
Eaddy, M
Grogg, A
Locklear, J
机构
[1] Janssen Med Affairs LLC, Outcomes Res, Titusville, NJ 08560 USA
[2] Appl Hlth Outcomes, Palm Harbor, FL USA
关键词
schizophrenia; compliance; resource utilization; retrospective claims review;
D O I
10.1016/j.clinthera.2005.02.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Partial compliance with mental health medications has been associated with an increased risk of clinical worsening, relapse, and repeat hospitalization. Objective: The purpose of this study was to evaluate the effect of partial compliance of patients (diagnosed as having schizophrenia or bipolar disorder) with prescribed oral atypical and conventional antipsychotic agents and the corresponding impact oil resource utilization. Methods: Patients receiving antipsychotic agents in a large Southeastern Medicaid program were grouped according to their level of compliance. Compliance was measured by the continuous, multiple interval medications available methodology. Patients were deemed partially compliant if compliance was < 80%, compliant if compliance was 80% to 125%, and overly compliant if compliance was > 125%. Medical costs were modeled as a function of compliance while controlling for background covarlates. Logistic regression was used to model the probability of specific resource utilization. Results: A total of 7864 patients were included in this analysis. After controlling for background covariates, partially compliant patients were 49.0% (95% CI, 29.2%-71.7%) more likely than compliant patients to have an inpatient hospitalization and incurred 54.5% (P < 0.001) higher inpatient charges. Partially compliant patients were also 64% (P < 0.01) more likely than compliant patients to switch or augment therapy. Conclusion: Partial compliance was associated with an increased risk of hospitalization and switching or augmentation of therapy when compared with being compliant. Copyright (c) 2005 Excerpta Medica, Inc.
引用
收藏
页码:263 / 272
页数:10
相关论文
共 19 条
[1]  
DOCHERTY JP, 2002, 41 ANN M AM COLL NEU
[2]   Interventions to improve antipsychotic medication adherence: Review of recent literature [J].
Dolder, CR ;
Lacro, JP ;
Leckband, S ;
Jeste, DV .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (04) :389-399
[3]  
Dubyna J, 1996, J Psychiatr Ment Health Nurs, V3, P297, DOI 10.1111/j.1365-2850.1996.tb00129.x
[4]   Adherence to treatment with antipsychotic medication and health care costs among medicaid beneficiaries with schizophrenia [J].
Gilmer, TP ;
Dolder, CR ;
Lacro, JP ;
Folsom, DP ;
Lindamer, L ;
Garcia, P ;
Jeste, DV .
AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (04) :692-699
[5]  
Johnson Brian F., 1994, Am J Ther, V1, P260, DOI 10.1097/00045391-199412000-00003
[6]   COMPLIANCE, QUALITY ASSURANCE AND STANDARDS FOR RELAPSE PREVENTION IN SCHIZOPHRENIA [J].
KISSLING, W .
ACTA PSYCHIATRICA SCANDINAVICA, 1994, 89 :16-24
[7]   Non-adherence to antipsychotic medication regimens: associations with resource use and costs [J].
Knapp, M ;
King, D ;
Pugner, K ;
Lapuerta, P .
BRITISH JOURNAL OF PSYCHIATRY, 2004, 184 :509-516
[8]   Schizophrenia costs and treatment cost-effectiveness [J].
Knapp, M .
ACTA PSYCHIATRICA SCANDINAVICA, 2000, 102 :15-18
[9]   Patient compliance with drug therapy in schizophrenia -: Economic and clinical issues [J].
Lindström, E ;
Bingefors, K .
PHARMACOECONOMICS, 2000, 18 (02) :105-124
[10]   HOW MEDICATION COMPLIANCE AFFECTS OUTCOME [J].
MANN, JJ .
PSYCHIATRIC ANNALS, 1986, 16 (10) :567-&